About

Publications While At HealthPartners

selected publications

Journal Article

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. 

Neuro-Oncology. 2023

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 

Neurooncol Adv. 2023

Contact

full name

J. S. Wefel

Quick Info

 

Collaboration

Co-author network

Map of science